1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Understanding 5-Fluorouracil & its Drug Master File

Admin
18 March 2024

Introduction: DMF

The Drug Master File is a confidential document submitted to the regulatory authorities by pharmaceutical manufacturers. Detailed information on the production process, quality control and safety of an active pharmaceutical ingredient API is included. The Drug Master File (DMF) shall serve as a reference for regulatory authorities in the approval process of medicinal products. In this blog, we will take a look at the importance of DMF for 5-Fluorouracil (5-FU), its mechanism of action, clinical strategies, global market impact, and role of top pharma database service provider in India for providing insights related to it.

5-Fluorouracil (5-FU)

In many cancers, 5-FU is used and colorectal cancer is widely used. It's been around since the 1950s, when researchers discovered that rat hepatoma metabolized uracil, a pyrimidine base found in RNA, more rapidly than normal tissues. This led to the development of fluoropyrimidines, with 5-FU at the front.

Mechanism of Action

There are two major mechanisms responsible for the cytotoxicity of 5-FU:

Incorporation into RNA and DNA: During replication, the metabolites of 5FUs are misincorporated into RNA and DNA disrupting normal cell processes.
Thymidylate Synthase (TS) Inhibition: TS, a key enzyme involved in the synthesis of nucleotides, is inhibited by 5-FU. The production of thymidine is reduced, impairing DNA replication and repairing.

Clinical Applications:

Cancer Treatment: In the treatment of various cancers, including colorectal, breast, stomach, and skin cancers, 5-FU is widely used. It is often administered intravenously as part of combination chemotherapy regimens or as a continuous infusion.
Topical Treatment: For the treatment of actinic keratoses, basal cell carcinomas and superficial squamous cell carcinomas, 5-FU is used in dermatology. It is an efficient treatment for noninvasive, skin cancer because of its ability to stimulate local cytotoxicity.

Side Effects:

Despite its therapeutic benefits, 5-FU therapy is associated with a spectrum of side effects ranging from mild to severe. Common side effects are nausea, vomiting, diarrhoea, mucositis, myelosuppression and skin reactions such as erythema, desquamations or photosensitivity.

Clinical Strategies

Several strategies have been identified to increase the anticancer activity of 5-fluorouracil:

Leucovorin and Methotrexate Co-treatment: Several strategies have been identified to increase the anticancer activity of 5fluorouracil.
Predictive Biomarkers: mRNA and protein expression levels of TS predict tumor sensitivity to 5-FU.

5-FU Drug Master File Details

Drug Name: 5-Fluorouracil (5-FU)
Purpose: Provide comprehensive information on the manufacture, quality and safety of 5-FU.
Contents

Manufacturing process details

Analytical methods

Stability data

Impurity profiles

Validation reports

Safety assessments

Importance of 5-FU DMF

Regulatory Compliance: Compliance with regulatory standards is ensured by the Drug Master File.
Accelerated Approvals: Approval of a Drug Master File (DMF) is an accelerated process for the approval of medicinal products.
Confidentiality: The DMFs protect proprietary information, and they allow regulatory access.

Future Perspectives

The scope of the 5FU DMF shall be expanded as research progresses to include:

New Manufacturing Techniques: Innovations in the synthesis and purification process.
Safety Enhancements: Improved impurity profiles.
Biosimilar: DMF for the biosimilar version of 5FU.

Chemxpert Database

In order to improve our understanding of the effects, mechanism and potential toxicity of 5-FU, Chemxpert is a top pharma database service provider in India that benefits both researchers and healthcare professionals.

Conclusion

In conclusion, its importance has been underlined by the evolution of 5 fluorouracil from being a top anticancer agent to an important factor for cancer therapy. Important documentation necessary to approve and ensure patient safety is required for the administration of 5-Fluorouracil Drug Master File (DMF). Innovative ideas and customized medicinal products will shape the future for fluorouracil.